press_release_conclusion: Two effective treatments benefit up to 60 per cent of patients with Chronic Fatigue Syndrome or Myalgic Encephalomyelitis (CFS/ME), according to a collaborative trial by King’s College London and colleagues from Queen Mary, University London, and the University of Edinburgh, published in The Lancet today.
abstract_conclusion: CBT and GET can safely be added to SMC to moderately improve outcomes for chronic fatigue syndrome, but APT is not an effective addition.